Top news of the week: 12.05.2020.
#CoronaVirus #biotechnology #CoronaOutbreak #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals #Biopharma #ICYMI
Companies And Industries
Biopharma Update on the Novel Coronavirus: May 7
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/qNEbf9A40P
OpenBiopharma Update on the Novel Coronavirus: May 7
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 7, 2020.
Biopharma Update on the Novel Coronavirus: May 11
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/TIQMrQiA0W
OpenBiopharma Update on the Novel Coronavirus: May 11
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
#ICYMI: #Biopharma Update on the Novel #Coronavirus: May 6 https://t.co/3nFrqXEiR8 https://t.co/4xCZtgBiaM
OpenBiopharma Update on the Novel Coronavirus: May 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 6, 2020.
The Dish’s Weekly Biotechnology News Wrap Up – May 8, 2020
This week's headlines include: Trump’s ‘Operation Warp Speed’ Aims to Rush Coronavirus Vaccine, WHO launches ambitious global project to develop Covid-19 medical products, US Preps For ...
CSL will create its therapy by collecting blood from people who have recovered and then tapping their virus-fighting antibodies to help those struggling to battle the disease. https://t.co/VSiIjT9V1k
OpenCSL Behring joins pandemic R&D fight with antibody work
Australia’s largest biotech company CSL says it is working on a plasma-based therapy for patients with more severe forms of COVID-19.
Top Medial Body Partners With Bharat Biotech To Develop COVID-19 Vaccine - let’s hope for the best https://t.co/drfEG2BJyM
OpenTop Medial Body Partners With Bharat Biotech To Develop COVID-19 Vaccine
Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19, the top health research body ...
Prominent Broad Institute scientist leaves to lead R&D at Genentech
Aviv Regev, a core institute member of the Broad Institute of MIT and Harvard, will become head of Genentech research and early development on Aug. 1.
Association of Biotechnology Led Enterprises - good news on India vaccine front @PremasLifeSc @ABLE_INDIA https://t.co/srn0Otx0T6
OpenPremas Biotech ready to start trials of triple antigen COVID-19 vaccine
“We have filed the relevant applications to start pre-clinical trials of the COVID-19 vaccine,” said Dr Prabuddha Kundu, Founder and CEO of Premas Biotech.“ Using the D-CryptTM …